Effects of Physical Exercise Timing On Strength and Cardiometabolic Health
EPOCH
1 other identifier
interventional
152
1 country
1
Brief Summary
Physical exercise is well known to improve human health. Current guidelines provide recommendations on the frequency, intensity, type and duration of exercise. However, they do not provide recommendations for the time of day, exercise should be performed. This is surprising considering that the influence of timing of behaviors such as sleep or nutrition as well as the impact of the circadian timing system on health are well documented. Further, there is evidence for diurnal variation in maximum performance which enables individuals to exercise with different intensities at different times of day, which in the long term might affect physical adaptations to exercise. Thus, this research study investigates if exercise timing impacts human health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
October 2, 2023
CompletedStudy Start
First participant enrolled
November 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2025
CompletedJune 25, 2025
June 1, 2025
1.6 years
September 18, 2023
June 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Maximum strength
Mean value of the maximum isometric strength assessed at four different times of the day with an isometric mid-thigh pull on a force plate.
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
Secondary Outcomes (3)
Glucose control
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
Body composition
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
Cardiorespiratory fitness
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
Study Arms (3)
Control
NO INTERVENTIONSingle life-style coaching session
Exercise Time 1
EXPERIMENTALPhysical exercise intervention taking place at one time of the day
Exercise Time 2
EXPERIMENTALPhysical exercise intervention taking place at another time of day
Interventions
Two strength training session per week and one endurance training session per week
Eligibility Criteria
You may qualify if:
- BMI 18.5 - 30 kg/m2
You may not qualify if:
- Structured resistance training within the last six months
- Ongoing shift work
- Irregular bedtime (\> 2 hours variation in habitual bed time)
- Smoking
- Travels across more than two time zones within the last four weeks
- Inability to follow the study procedures (e.g. due to language barriers, psychological disorders, dementia, etc.)
- Known pregnancy or lactating women
- Participation in any other clinical trial within the last four weeks
- Medical condition that is a contra indicator for resistance training, endurance training, or exercising until maximum exhaustion including insufficiently controlled blood pressure (systolic \> 170 mmHg, diastolic \> 100 mmHg), ongoing cancer treatment, unstable angina pectoris, uncontrolled bradyarrhythmia or tachyarrhythmia, severe uncorrected valvular heart disease, clinically relevant acute infection, any form of musculoskeletal injury, orthopedic problems or decompensated cardiovascular disease
- Insulin dependent diabetes
- Participants using metformin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Basel
Basel, 4052, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raphael Knaier, PhD
University of Basel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher Group leader: Circadian Exercise
Study Record Dates
First Submitted
September 18, 2023
First Posted
October 2, 2023
Study Start
November 21, 2023
Primary Completion
June 24, 2025
Study Completion
June 24, 2025
Last Updated
June 25, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After completion of study
Anonymized data will be provided in a data repository in accordance to FAIR principles